{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:52:35Z","timestamp":1793652755690,"version":"4.5.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.jns.2008.08.031","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T13:39:54Z","timestamp":1223732394000},"page":"41-44","source":"Crossref","is-referenced-by-count":31,"title":["The role of osteopontin: A shared pathway in the pathogenesis of multiple sclerosis and osteoporosis?"],"prefix":"10.1016","volume":"276","author":[{"given":"Ayse","family":"Alt\u0131nta\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guher","family":"Saruhan-Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulcin","family":"Benbir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim","family":"Purisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2008.08.031_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jneuroim.2004.09.004","article-title":"Plasma osteopontin levels in multiple sclerosis","volume":"158","author":"Comabella","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2008.08.031_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0165-5728(01)00481-7","article-title":"Identifying disease modifying genes in multiple sclerosis","volume":"123","author":"Kantarci","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2008.08.031_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00004-3","article-title":"Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients","volume":"136","author":"Niino","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2008.08.031_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI117718","article-title":"The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro","volume":"95","author":"Liaw","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2008.08.031_bib5","first-page":"74","article-title":"Induction and temporal changes of osteopontin mRNA and protein in the brain following systemic lipopolysaccharide injection","volume":"141","author":"Choi","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2008.08.031_bib6","doi-asserted-by":"crossref","unstructured":"Choi JS, Park HJ, Cha JH, Chung JW, Chun MH, Lee MY., Induction and temporal changes of osteopontin mRNA and protein in the brain following systemic lipopolysaccharide injection. J Neuroimmunol 2003: 141:65-73.","DOI":"10.1016\/S0165-5728(03)00223-6"},{"key":"10.1016\/j.jns.2008.08.031_bib7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ni0901-762","article-title":"Multiple sclerosis: a two-stage disease","volume":"2","author":"Steinman","year":"2001","journal-title":"Nature Immunol"},{"key":"10.1016\/j.jns.2008.08.031_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)81107-1","article-title":"Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system","volume":"85","author":"Steinman","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jns.2008.08.031_bib9","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.1078985","article-title":"Comment on \u201cThe influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease\u201d","volume":"299","author":"Blom","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jns.2008.08.031_bib10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/eji.200535618","article-title":"The osteopontin \u2014 CD44 pathway is superfluous for the development of autoimmune myocarditis","volume":"36","author":"Abel","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jns.2008.08.031_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00415-003-1120-2","article-title":"Osteopontin gene and clinical severity of multiple sclerosis","volume":"25","author":"Hensiek","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2008.08.031_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.gene.6363952","article-title":"Osteopontin polymorphisms and disease course in multiple sclerosis","volume":"4","author":"Caillier","year":"2003","journal-title":"Genes Immun"},{"key":"10.1016\/j.jns.2008.08.031_bib13","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1062960","article-title":"The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease","volume":"294","author":"Chabas","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jns.2008.08.031_bib14","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.4049\/jimmunol.168.5.2096","article-title":"Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1\/osteopontin-deficient mice","volume":"168","author":"Jansson","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2008.08.031_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1097-4644(1998)72:30\/31+<92::AID-JCB13>3.0.CO;2-A","article-title":"Osteopontin expression and function: role in bone remodeling","volume":"31","author":"Denhardt","year":"1998","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jns.2008.08.031_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0888-7543(90)90191-V","article-title":"cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)","volume":"7","author":"Young","year":"1990","journal-title":"Genomics"},{"key":"10.1016\/j.jns.2008.08.031_bib17","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.yexcr.2006.06.003","article-title":"Osteopontin is associated with nuclear factor \u03baB gene expression during tail-suspension-induced bone loss","volume":"312","author":"Ishijima","year":"2006","journal-title":"Exp Cell Res"},{"issue":"2","key":"10.1016\/j.jns.2008.08.031_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200319190","article-title":"Osteopontin: a bridge between bone and the immune system","volume":"112","author":"Gravallase","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2008.08.031_bib19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1191\/1352458503ms966oa","article-title":"Bone status in multiple sclerosis: beyond corticosteroids","volume":"9","author":"Tuzun","year":"2003","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2008.08.031_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B","article-title":"Review: cytokines and the pathogenesis of multiple sclerosis","volume":"45","author":"Navikas","year":"1996","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2008.08.031_bib21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.10606","article-title":"Elevated osteopontin levels in active relapsing\u2013remitting multiple sclerosis","volume":"53","author":"Vogt","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.08.031_bib22","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/brain\/122.12.2297","article-title":"Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules","volume":"122","author":"Duran","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.08.031_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s004150050313","article-title":"Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease","volume":"246","author":"McDonnell","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2008.08.031_bib24","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/WNL.48.6.1557","article-title":"Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging","volume":"48","author":"Giovannoni","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.08.031_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.08.031_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2004.06.007","article-title":"Osteopontin levels and increased disease activity in relapsing\u2013remitting multiple sclerosis patients","volume":"155","author":"Vogt","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2008.08.031_bib27","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.51.4.1161","article-title":"Fracture history and bone loss in patients with MS","volume":"51","author":"Cosman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.08.031_bib28","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis","volume":"44","author":"Nieves","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.08.031_bib29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.1996.00550080071014","article-title":"Sporadic glucocorticoid pulses and osteoporosis in multiple sclerosis","volume":"53","author":"Schwid","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2008.08.031_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002239900309","article-title":"Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use","volume":"61","author":"Formica","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jns.2008.08.031_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1212\/WNL.45.6_Suppl_6.S4","article-title":"Differential aspects of cytokines in the immunopathology of MS","volume":"45","author":"Lucas","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.08.031_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002239900570","article-title":"Bone and cytokines: beyond IL-1, 11-6 and TNF-a","volume":"64","author":"Rifas","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jns.2008.08.031_bib33","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1096\/fasebj.7.15.8262332","article-title":"Osteopontin: a protein with diverse functions","volume":"7","author":"Denhardt","year":"1993","journal-title":"FASEB J"},{"key":"10.1016\/j.jns.2008.08.031_bib34","first-page":"225","article-title":"Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1\/osteopontin gene","volume":"13","author":"Patarca","year":"1993","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jns.2008.08.031_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2005.02.020","article-title":"Osteopontin gene halotypes correlate with multiple sclerosis development and progression","volume":"163","author":"Chiocchetti","year":"2005","journal-title":"J Neuroimmunol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08004383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08004383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:39:00Z","timestamp":1557833940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08004383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0022510X08004383"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.08.031","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}